|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In this experience neither prior PCI nor WBRT improved survival or local tumor control in SCLC patients who underwent SRS for new or recurrent brain disease.
|
31230250 |
2019 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Hsa-let-7e-5p over-expression inhibited PCI-37B tumor growth <i>in vivo</i>.
|
31205553 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Neither high PCI nor rapid tumour growth following primary tumour resection should, therefore, be a contraindication for CRS/HIPEC in patients with PMCA.
|
31810947 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
After the multivariate analyses, the impossibility of performing a complete cytoreduction (CC-score = 1, HR: 4.56, p = 0.012), the PSDSSov (III-IV, HR: 3.59, p = 0.024), a high (>20) PCI (HR: 3.16, p = 0.032), and the histological type of the tumor (G3, HR: 2.28, 95% CI: 1.14-8.14, p = 0.033) were factors that were independently related with lower DFS.
|
30851912 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
A total of 142 PIPAC procedures were scheduled in 71 consecutive patients with PM from gastric (<i>n</i> = 26), colorectal (<i>n</i> = 17), hepatobiliary/pancreatic (<i>n</i> = 9), ovarian (<i>n</i> = 6), appendiceal (<i>n</i> = 5) origin, pseudomyxoma peritonei (<i>n</i> = 4), and other tumors (<i>n</i> = 3).Mean age was 58 ± 13 years.Patients were heavily pretreated.Mean PCI was 19 ± 13.
|
30473706 |
2018 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors.
|
28265007 |
2017 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Studies suggest that SERPINA5 may play a role in hemostasis, in male reproduction, in host defense, and as a tumor suppressor.
|
27989561 |
2017 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Specificity of both antibodies and their ability to discriminate tumor from non-tumor cells were assessed in vitro with human fibroblasts and PCI-1 HNSCC cell lines, and ex vivo on primary HNSCC samples (n = 11) and healthy mucosa (n = 5).
|
28106950 |
2017 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In non-induced co-cultures, BMSC were able to suppress Vimentin in PCI-13 as a marker of tumor transition.
|
28318921 |
2017 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
We also confirmed a potent inhibitory effect on tumor cell growth in human BTC cell lines treated with PCI-24781.
|
22326466 |
2012 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
We propose that the putative tumor suppressor genes Dusp 4 and Serpina 5 provide a major clue to the indolent behavior of SBTs.
|
16087957 |
2005 |
|
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
We examined the effect of Ad CEA-N116Y on the metastatic growth of PCI-43 colonies in liver, which was generated by tumor injection into the spleen of nude mice.
|
10757026 |
2000 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
PCI:SG231 was tumorigenic in immunosuppressed nude mice and was histologically similar to the original tumor.
|
2176543 |
1990 |